The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...

The 2026 agenda is anchored by a distinguished roster of speakers who are actively redefining the boundaries of science, ...

In a subgroup of black women enrolled in a US breast cancer registry called BEST, women deemed to have low-risk tumours using the MammaPrint test had a 97.7% recurrence-free rate after 10 years, the ...

"Through the integration of virtual control groups, EMA also seeks to improve the relevance and predictability of ...

Three behavioural phenomena are particularly consequential in screening and prevention research: ...

Mitapivat has been approved in the US under the Pyrukynd trade name since 2022 as a treatment for haemolytic anaemia in ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...

The FDA has ramped up the pressure on Amgen to withdraw Tavneos for a rare vasculitis condition from the market, with a ...

The NHS in England will make Novo Nordisk's Wegovy available to around 1.2 million people in order to reduce their risk of ...

Johnson & Johnson has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of its EGFRxMET bispecific antibody, for all the indications approved for the current, intravenous formulation.

Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinical trials category, with the launch of a new institute that pledges to increase and diversify community ...